Pharmanutra SpA
MIL:PHN
Wall Street
Price Targets
PHN Price Targets Summary
Pharmanutra SpA
According to Wall Street analysts, the average 1-year price target for
PHN
is 83.98 EUR
with a low forecast of 74.74 EUR and a high forecast of 92.4 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHN's stock price target?
Price Target
83.98
EUR
According to Wall Street analysts, the average 1-year price target for
PHN
is 83.98 EUR
with a low forecast of 74.74 EUR and a high forecast of 92.4 EUR.
What is Pharmanutra SpA's Revenue forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Pharmanutra SpA's revenue is
17%.
The projected
CAGR
for the next 4 years is
15%.
What is Pharmanutra SpA's Operating Income forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Pharmanutra SpA's operating income is
21%.
The projected
CAGR
for the next 4 years is
14%.
What is Pharmanutra SpA's Net Income forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
Pharmanutra SpA's net income is
20%.
The projected
CAGR
for the next 3 years is
19%.
